- Home
- MCRB vs NCTY Comparison
MCRB vs NCTY Comparison
Compare MCRB & NCTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRB
- NCTY
- Stock Information
- Founded
- MCRB 2010
- NCTY 1999
- Country
- MCRB United States
- NCTY China
- Employees
- MCRB N/A
- NCTY N/A
- Industry
- MCRB Biotechnology: Pharmaceutical Preparations
- NCTY Business Services
- Sector
- MCRB Health Care
- NCTY Consumer Discretionary
- Exchange
- MCRB Nasdaq
- NCTY Nasdaq
- Market Cap
- MCRB 81.2M
- NCTY 95.8M
- IPO Year
- MCRB 2015
- NCTY 2004
- Fundamental
- Price
- MCRB $7.06
- NCTY $11.91
- Analyst Decision
- MCRB Hold
- NCTY
- Analyst Count
- MCRB 5
- NCTY 0
- Target Price
- MCRB $73.67
- NCTY N/A
- AVG Volume (30 Days)
- MCRB 146.8K
- NCTY 110.5K
- Earning Date
- MCRB 05-07-2025
- NCTY 01-01-0001
- Dividend Yield
- MCRB N/A
- NCTY N/A
- EPS Growth
- MCRB N/A
- NCTY N/A
- EPS
- MCRB 0.03
- NCTY N/A
- Revenue
- MCRB N/A
- NCTY $15,305,175.00
- Revenue This Year
- MCRB N/A
- NCTY N/A
- Revenue Next Year
- MCRB N/A
- NCTY N/A
- P/E Ratio
- MCRB $213.09
- NCTY N/A
- Revenue Growth
- MCRB N/A
- NCTY N/A
- 52 Week Low
- MCRB $7.18
- NCTY $5.75
- 52 Week High
- MCRB $30.60
- NCTY $20.59
- Technical
- Relative Strength Index (RSI)
- MCRB 33.07
- NCTY 51.62
- Support Level
- MCRB $8.92
- NCTY $10.30
- Resistance Level
- MCRB $9.97
- NCTY $12.48
- Average True Range (ATR)
- MCRB 1.08
- NCTY 0.85
- MACD
- MCRB -0.06
- NCTY 0.03
- Stochastic Oscillator
- MCRB 10.61
- NCTY 62.40
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
About NCTY The9 Limited American Depository Shares
The9 Ltd operates a cryptocurrency mining business. It provides computing power, or hash rate, to a Bitcoin mining pool and is entitled to receive a fractional share of Bitcoin award from the Bitcoin mining pool in return. The company generates its revenues from customers in Greater China and other areas.